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Oral human cytomegalovirus 
prevalence and its relationships with 
periodontitis and Porphyromonas 
gingivalis in Japanese adults: a cross-
sectional study
Objective: This study aimed to clarify the association between oral human 
cytomegalovirus (HCMV) and periodontitis in Japanese adults. Methodology: 
In total, 190 patients (75 men and 115 women; mean age, 70.2 years) who 
visited Hiroshima University Hospital between March 2018 and May 2020 
were included. Oral rinse samples were taken to examine the presence of 
HCMV DNA using real-time polymerase chain reaction (PCR). P. gingivalis was 
detected by semi-quantitative PCR analysis. Results: HCMV DNA was present 
in nine of 190 patients (4.7%). There were significant associations between 
HCMV presence and the presence of ≥4-mm-deep periodontal pockets with 
bleeding on probing (BOP) (P<0.01) and ≥6-mm-deep periodontal pockets 
with BOP (P=0.01). However, no significant relationship was observed 
between HCMV presence and periodontal epithelial surface area scores. 
Logistic regression analysis revealed that the presence of ≥4-mm-deep 
periodontal pockets with BOP was significantly associated with HCMV (odds 
ratio, 14.4; P=0.01). Propensity score matching was performed between 
patients presenting ≥4-mm-deep periodontal pockets with BOP (i.e., active 
periodontitis) and patients without ≥4-mm-deep periodontal pockets with 
BOP; 62 matched pairs were generated. Patients who had ≥4-mm-deep 
periodontal pockets with BOP showed a higher rate of HCMV presence (9.7%) 
than those who lacked ≥4-mm-deep periodontal pockets with BOP (0.0%). 
There was a significant relationship between HCMV presence and ≥4-mm-
deep periodontal pockets with BOP (P=0.03). A significant relationship 
was found between HCMV/P. gingivalis DNA presence and ≥4-mm-deep 
periodontal pockets with BOP (P=0.03). Conclusions: Coinfection of oral 
HCMV and P. gingivalis was significantly associated with active periodontitis. 
Moreover, interactions between oral HCMV and P. gingivalis may be related 
to the severity of periodontal disease.
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Introduction
Human cytomegalovirus (HCMV) is a double-
stranded DNA virus belonging to the Herpesviridae 
family, along with herpes simplex virus, Epstein-Barr 
virus (EBV) and varicella zoster virus.1 HCMV has a 
235-kb DNA genome encoding more than 165 open 
reading frames.2 Most children become infected with 
HCMV during the first year of life.3 HCMV generally 
remains latent in host cells throughout the lifespan 
of infected individuals, but it can be reactivated 
in immunocompromised hosts.4 HCMV infection is 
commonly regarded as a life-threatening infection 
in patients infected with human immunodeficiency 
virus and patients who have undergone organ 
transplantation.5
The oral cavity is a common site for primary human 
herpesvirus infection. HCMV prevalence has varied 
in patients with gingivitis or chronic periodontitis.6,7 
Periodontitis is a polymicrobial infectious disease 
affecting gingiva, tooth-supporting connective 
tissue, and alveolar bone. Periodontal disease 
destroys the crevicular epithelium, allowing HCMV 
to infect epithelial cells in the periodontal pocket. 
Therefore, oral HCMV prevalence is associated with 
inflammation in periodontal tissue. HCMV has been 
found in unstimulated whole saliva from people with 
periodontitis, indicating that saliva may play a vital 
role in the transmission of HCMV to others.8 To the 
best of our knowledge, little is known regarding the 
relationship of HCMV with inflamed periodontal pocket/
periodontal inflamed surface area (PISA) in Japanese 
adults. PISA is a useful indicator for evaluating the total 
amount of inflamed periodontal tissue.9 In this cross-
sectional study, we investigated oral HCMV prevalence 
and its relationship with inflamed periodontal pockets. 
Furthermore, we investigated the association of 
HCMV with periodontal disease-related bacteria (i.e., 
P. gingivalis). The fimA fimbria of P. gingivalis is a 
virulence factor for P. gingivalis.10 Type II and IV 
fimA are closely associated with periodontal disease.10 
Therefore, we investigated the fimA genotype to clarify 
the association between the HCMV prevalence and 
fimA genotype. Furthermore, we performed propensity 
score matching to analyze the relationship of HCMV 
with active periodontitis. 
Methodology
In this study, 201 patients who visited the 
Department of Oral Health of Hiroshima University 
Hospital between March 2018 and May 2020 were 
recruited. The study design was approved by the 
Research Ethics Committee of Hiroshima University 
(approval no. E-1115), and all patients provided 
written informed consent form. We included ≥20-year-
old adults who had consented to participate in this 
study. Immunocompromised patients [i.e., patients 
who received chemotherapy (n=11), those with severe 
immunodeficiency (n=0), and those with autoimmune 
disease, who received immunosuppressant therapies 
(n=0)] were excluded, considering that such patients 
are thought to be more susceptible to microbial 
infection in the oral cavity compared with healthy 
individuals. Therefore, 190 patients (75 men and 115 
women; mean age, 70.2 years) were included in this 
study. The estimated sample size required for Mann–
Whitneys U test and χ2 test analyses, as determined 
using the G*Power (version 3.1.9.4, Heinrich-Heine-
Universität Düsseldorf, Düsseldorf, Germany), were 
134 and 88 patients, respectively; these estimations 
used a 5% significance level and 80% statistical power. 
Effect size (i.e., 0.5 for Mann–Whitneys U and 0.3 
for χ2 test) was used for sample size estimation, in 
accordance with the approach described by Cohen.11
Oral investigation
Probing depth and bleeding on probing (BOP) were 
assessed at six sites (i.e., mesiobuccal, mesiolingual, 
buccal, lingual, distobuccal, and distolingual) for each 
individual tooth by an experienced dentist. Intra-
rater reliability of pocket probing measurement by 
the dentist was examined. The calculated value of 
intraclass correlation coefficient was 0.83, suggesting 
a reproducible assessment of pocket depth. The 
presence of bleeding at one site was recorded as 
a BOP-positive result. The PISA and periodontal 
epithelial surface area (PESA) scores were calculated in 
accordance with previously described method.9 Plaque 
control scores were determined by experienced dental 
hygienists in accordance with the method described 
by O’Leary et al., using a plaque-disclosing agent to 
examine dental plaque accumulation.12 The number 
of remaining teeth and use of dentures were also 
recorded. 
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Oral rinse sample collection and DNA extraction
Oral rinse samples were collected by asking the 
patients to rinse their mouths with saline for 15 
sec. Samples were collected in sterile plastic tubes 
and immediately centrifuged. The supernatant was 
decanted and the pellets were stored at -80°C for 
subsequent DNA extraction. DNA was extracted using 
a PureLink™ Microbiome DNA Purification kit (Thermo 
Fisher Scientific, Waltham, MA, USA), in accordance 
with the manufacturer’s protocol.
HCMV DNA detection by real-time PCR
Real-time PCR analysis was performed to determine 
HCMV DNA copy number in samples using a CFX 
connect real-time PCR detection system (Bio-Rad, 
Hercules, CA, USA) in accordance with a previous 
study.13 The CMV PPS Set (Nippon Genetics Co., Ltd., 
Tokyo, Japan) was used, including PCR primer, probe, 
and standard PCR products, for HCMV DNA detection. 
HCMV strain AD169 was used to prepare the DNA 
control for PCR. Ten-fold dilutions of the standard PCR 
products (copy numbers ranging between 2.0 and 
2.0×104) were used to generate a standard curve of 
HCMV DNA, in accordance with the manufacturer’s 
protocol (Figure 1). Real-time PCR analysis was 
performed using FastGene™ QPCR Probe Mastermix 
w/ROX (Nippon Genetics Co., Ltd.). Amplification was 
performed with the following thermocycler protocol: 
95°C for 10 min; followed by 50 cycles of 95°C for 10 
sec and 62°C for 1 min; and then 40°C for 30 sec. Copy 
numbers above the detection limit in a standard curve 
for HCMV DNA were considered as positive results. 
P. gingivalis detection and fimA genotyping 
by PCR
In accordance with the method used in our previous 
study, P. gingivalis was detected by PCR with specific 
DNA primer sets.14 Furthermore, the fimA genotype of 
P. gingivalis was examined using specific primers, as 
described previously.15 PCR products were amplified 
with GoTaq® Green Master Mix (Promega, Madison, WI, 
USA). Amplification was performed with the following 
thermocycler protocol: initial melting at 95°C for 2 
min; followed by 30 cycles of 95°C for 1 min, 57°C 
for 1 min, and 72°C for 1 min. PCR products were 
electrophoresed on 2% agarose gels and stained with 
ethidium bromide. The presence of PCR product in 
the expected size was regarded as a positive result.  
Statistical analysis
The Mann–Whitneys U test was used to compare 
differences in clinical parameters between groups. 
When necessary χ2 test or Fisher’s exact test were 
used. We performed residual analysis to determine 
which cell had a significant difference in the χ2 test 
for comparison between four groups. If the adjusted 
standardized residue was ≥1.96, the cells were 
considered to present significantly more subjects than 
expected. Bimodal logistic regression analysis was 
conducted by a step-wise model, using HCMV as the 
dependent variable; variables with a P-value inferior 
to 0.2 in univariate analysis were used as independent 
variables. The Hosmer–Lemeshow test result was 
not statistically significant (i.e., P>0.05), suggesting 
that the model exhibited good fitness. A propensity 
score-matched analysis was performed to adjust for 
confounders effects. Propensity scores were calculated 
by logistic regression analysis of 10 clinical factors 
(i.e., age, sex, hypertension, diabetes, hyperlipidemia, 
stroke, heart disease, smoking, remaining teeth, and 
denture use). Caliper of 0.25 standard deviations of 
the propensity score was used for analysis. Statistical 
analysis was performed using SPSS Statistics, version 
24.0 (IBM Corp., Armonk, NY, USA). P<0.05 indicated 
a statistically significant difference.
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A standard curve was generated estimated by plotting obtained 
CT values against HCMV copy numbers ranging between 2.0 
and 2.0x104.
Figure 1- Standard curve indicating human cytomegalovirus 
(HCMV) copy number vs CT values
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Results
Association between HCMV DNA presence and 
clinical factors
HCMV DNA was present in nine of 190 patients 
(4.7%). Table 1 summarizes the relationships of HCMV 
DNA presence with clinical factors. Men presented 
significantly higher rate of HCMV DNA presence, 
compared with women (P=0.03, Fisher’s exact test). 
However, no significant relationships were found 
between HCMV DNA presence and other clinical factors 
(i.e., age, medical history, smoking, remaining teeth, 
and denture use). 
Association of HCMV DNA presence with dental 
plaque accumulation and periodontal health 
condition
Following, associations of HCMV DNA presence 
with plaque control score and periodontal health 
condition were assessed (Table 2). Plaque control 
scores were higher in patients with HCMV DNA than in 
patients without HCMV DNA; however, this difference 
was not statistically significant. A total of 67 of 190 
(35.3%) patients had ≥4-mm-deep periodontal 
pockets with BOP (i.e., active periodontitis). Six of 
the 65 (9.2%) patients with ≥6-mm-deep periodontal 
pockets presented HCMV DNA presence; no significant 
association was found between HCMV DNA presence 
and probing depth. Patients who had ≥4-mm-deep 
periodontal pockets with BOP demonstrated a higher 
rate of HCMV DNA presence (11.9%), compared 
with patients who lacked ≥4-mm-deep periodontal 
pockets with BOP (0.8%). Furthermore, patients 
who had ≥6-mm-deep periodontal pockets with BOP 
demonstrated a higher rate of HCMV DNA presence 
(13.3%) in comparison with patients without ≥6-mm-
deep periodontal pockets with BOP (2.1%). There was 
a significant association of HCMV DNA presence with 
≥4-mm-deep periodontal pockets with BOP (P<0.01, 
Fisher’s exact test), as well as with ≥6-mm periodontal 
pockets with BOP (P=0.01, Fisher’s exact test). The 
mean values of PISA and PESA were higher in patients 
without HCMV DNA than in patients with HCMV DNA; 
however, these differences were not statistically 
significant. Post-hoc statistical analysis revealed that 
the statistical power of the χ2 test was ≥0.8 (i.e., high 
statistical power), but the statistical power of the 
Mann-Whitneys U-test was <0.8 (i.e., low statistical 
power). These results suggested a possible β error 
due to the low prevalence of HCMV.11 Therefore, it 
was necessary to consider the probability of a β error 
when assessing the results of PCR, PISA, and PESA 
statistical analyses.
Associations of oral HCMV/P. gingivalis with 
periodontal health condition
Associations of HCMV/P. gingivalis DNA presence 
with the plaque control score and periodontal health 
condition were assessed (Table 3). A significant 
Clinical factor (n) HCMV
DNA
P-value
(-) (n=181) (+) (n=9)
Age 70.2±11.4 69.0±10.9 0.77
Age in years 0.63
   30-39 (2) 2 (100%) 0 (0.0%)
   40-49 (7) 6 (85.7%) 1 (14.3%)
   50-59 (22) 22 (100%) 0 (0.0%)
   60-69 (51) 47 (92.2%) 4 (7.8%)
   70-79 (67) 65 (97.0%) 2 (3.0%)
   80-89 (38) 36 (94.7%) 2 (5.3%)
90-99 (3) 3 (100%) 0 (0.0%)
Sex
  Men (75) 68 (90.7%) 7 (9.3%) 0.03
  Women (115) 113 (98.3%) 2 (1.7%)
Heart disease 
  No (179) 171 (95.5%) 8 (4.5%) 0.42
  Yes (11) 10 (90.9%) 1 (9.1%)
Stroke Diabetes
  No (184) 176 (95.7%) 8 (4.3%) 0.26
  Yes (6) 5 (83.3%) 1 (16.7%)
Hypertension
  No (142) 136 (95.8%) 6 (4.2%) 0.69
  Yes (48) 45 (93.8%) 3 (6.3%)
Diabetes
  No (166) 157 (94.6%) 9 (5.4%) 0.61
  Yes (24) 24 (100%) 0 (0.0%)
Hyperlipidemia
  No (155) 147 (94.8%) 8 (5.2%) 1.0
  Yes (35) 34 (97.1%) 1 (2.9%)
Smoking
 Non-smoker (161) 154 (95.7%) 7 (4.3%) 0.63
Current/former smoker 
(29)
27 (93.1%) 2 (6.9%)
Remaining teeth 23.4±6.2 20.7±6.4 0.07
Denture user
  Non-user (142) 135 (95.1%) 7 (4.9%) 1.0
  User (48) 46 (95.8%) 2 (4.2%)
P values less than 0.05 were considered statistically significant.
Abbreviation: HCMV, human cytomegalovirus.
Table 1- Associations of oral HCMV DNA with clinical parameters
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relationship was found between HCMV/P. gingivalis 
DNA presence and probing depth or ≥4-mm/≥6-mm-
deep periodontal pockets with BOP. Residual analysis 
revealed that HCMV-negative/P. gingivalis-positive 
and HCMV-positive/P. gingivalis-positive groups 
presented significantly more ≥4-mm-deep periodontal 
pockets with BOP. Additionally, the HCMV-positive/P. 
gingivalis-positive group presented significantly more 
≥6-mm-deep periodontal pockets with BOP. These 
results suggest that the presence of both HCMV and P. 
gingivalis is associated with deep periodontal pockets 
with BOP. 
 
Association of HCMV DNA presence with fimA 
genotypes of P. gingivalis
Out of 190 patients, 103 (54.2%) had P. gingivalis. 
Associations of HCMV DNA presence with fimA 
genotypes are summarized in Table 4. Type II fimA 
was the most common genotype among six genotypes 
in patients with P. gingivalis. However, no significant 
relationships were found between HCMV DNA presence 
and fimA genotypes.
Factor (n)                    HCMV DNA P-value
(-) (+)
Plaque Control Record scores (%) 35.1±18.2 41.5±18.4 0.33
Probing depth
<4 mm (75) 74 (98.7%) 1 (1.3%) 0.09
≥4 mm and <6 mm (50) 48 (96.0%) 2 (4.0%)
≥6 mm (65) 59 (90.8%) 6 (9.2%)
≥4 mm periodontal pocket with BOP
No (123) 122 (99.2%) 1 (0.8%) <0.01
Yes (67) 59 (88.1%) 8 (11.9%)
≥6 mm periodontal pocket with BOP
No (145) 142 (97.9%) 3 (2.1%) 0.01
Yes (45) 39 (86.7%) 6 (13.3%)
PISA (mm2) 201.0±215.9 114.8±85.1 0.46
PESA (mm²) 1219.7±1003.1 1071.6±349.5 0.84
P values less than 0.05 were considered statistically significant. Abbreviations: HCMV, human cytomegalovirus; P. gingivalis, 
Porphyromonas gingivalis; PISA, periodontal inflamed surface area; PESA, periodontal epithelial surface area; BOP, bleeding on probing.
Table 2- Associations of oral HCMV DNA with periodontal condition
Factor (n) HCMV(-)/P. 
gingivalis(-) 
(n=86)










Plaque Control Record scores (%) 32.1±19.7 25.0 37.6±16.7 44.2±18.5 0.10
Probing depth
<4 mm (75) 46 (53.5%)* 1 (0.0%) 28 (29.5%) 0 (0.0%) 0.01
≥4 mm and <6 mm (50) 22 (25.6%) 0 (0.0%) 26 (27.4%) 2 (25.0%)
≥6 mm (65) 18 (20.9%) 0 (0.0%) 41 (43.2%)* 6 (75.0%)*
≥4 mm periodontal pocket with BOP
No (123) 67 (77.9%)* 1 (100%) 55 (57.9%) 0 (0.0%) <0.01
Yes (67) 19 (22.1%) 0 (0.0%) 40 (42.1%)* 8 (100%)*
≥6 mm periodontal pocket with BOP
No (145) 74 (86.0%)* 1 (100%) 68 (71.6%) 2 (25.0%) 0.01
Yes (45) 12 (14.0%) 0 (0.0%) 27 (28.4%) 6 (75.0%)*
PISA (mm²) 173.8±148.1 180.8 227.3±264.2 101.6±88.0 0.78
PESA (mm²) 1127.1±304.5 1017 1306.0±1374.2 1080.8±382.0 0.98
P values less than 0.05 were considered statistically significant. *Adjusted standardized residue was greater than or equal to 1.96. 
Abbreviations: HCMV, human cytomegalovirus; P. gingivalis, Porphyromonas gingivalis; PISA, periodontal inflamed surface area; PESA, 
periodontal epithelial surface area; BOP, bleeding on probing.
Table 3- Associations of oral HCMV/P. gingivalis with periodontal condition
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 Independent clinical factors associated with 
HCMV by logistic regression analysis
Logistic regression analysis was performed to 
identify independent factors associated with HCMV 
DNA, using clinical parameters with P<0.2 (i.e., 
sex, remaining teeth, probing depth, ≥4-mm-deep 
periodontal pockets with BOP, and P. gingivalis 
presence) as independent variables. P values for 
the Hosmer–Lemeshow test were 0.23, indicating 
a good fit of the model. Logistic regression analysis 
demonstrated that the presence of ≥4-mm-deep 
periodontal pockets with BOP was significantly 
associated with HCMV presence (odds ratio, 14.4; 95% 
confidence interval, 1.74–119.68; P=0.01). 
Relationship of active periodontitis with HCMV 
DNA presence in propensity score-matched 
patients
Propensity score-matching was performed between 
patients who had ≥4-mm-deep periodontal pockets 
with BOP (i.e., patients with active periodontitis) and 
those who lacked ≥4-mm-deep periodontal pockets 
with BOP (i.e., patients without active periodontitis) 
using propensity scores generated based on 10 clinical 
factors: age, sex, heart disease, stroke, hypertension, 
diabetes, hyperlipidemia, smoking, remaining teeth, 
and denture use. In total, 124 propensity score-
matched patients (62 patients in matched pairs) 
were assessed by univariate analysis. None of the 10 
clinical variables were significantly associated with 
HCMV DNA presence (Table 5). Then, associations 
were investigated between deep periodontal pockets 
with bleeding and HCMV DNA or P. gingivalis presence. 
Patients who had ≥4-mm-deep periodontal pockets 
with BOP showed a higher rate of HCMV DNA 
presence (9.7%) in comparison with patients who 
lacked ≥4-mm-deep periodontal pockets with BOP 
(0.0%) (P=0.03, Fisher’s exact test) (Table 6). Also, 
a significant relationship was observed between P. 
gingivalis presence and ≥4-mm-deep periodontal 
pockets with BOP (P<0.01, Fisher’s exact test) (Table 
6). Furthermore, a significant relationship was found 
between HCMV/P. gingivalis DNA presence and 
≥4-mm-deep periodontal pockets with BOP (P=0.03).
Discussion
In a recent review, Slots reported that oral 
HCMV infection occurred in 40% of patients with 
chronic periodontitis and 6% in patients with healthy 
periodontal tissue.7 However, a low percentage of 
HCMV-positive cases was found in this study. Notably, 
many participants presented a stable periodontal 
condition without periodontal inflammatory signs 
or localized periodontal inflammation. Furthermore, 
immunocompromised patients were excluded from 
this study. These factors may be related to the 
low prevalence of HCMV. A previous meta-analysis 
suggested that oral HCMV and periodontitis are 
significantly associated.6 Notably, logistic regression 
analysis demonstrated that deep periodontal pockets 
with bleeding constitutes a significant factor for oral 
HCMV prevalence. Furthermore, deep periodontal 
pockets with bleeding was significantly associated 
with the presence of HCMV DNA in propensity score-
matched patients. Additionally, a significant association 
was found between the presence of both HCMV DNA 
and P. gingivalis and deep periodontal pockets with 
BOP. Our results strongly suggest that coinfection of 
oral HCMV and P. gingivalis is associated with active 
Factor (n) HCMV DNA P-value
(-) (+)
P. gingivalis
  Negative (87) 86 (98.9%) 1 (1.1%) 0.04
  Positive (103) 95 (92.2%) 8 (7.8%)
Type I fimA
  Negative (85) 80 (94.1%) 5 (5.9%) 0.14
  Positive (18) 15 (83.3%) 3 (16.7%)
Type Ib fimA
  Negative (90) 83 (92.2%) 7 (7.8%) 1.0
  Positive (13) 12 (92.3%) 1 (7.7%)
Type II fimA
  Negative (2) 2 (100%) 0 (0.0%) 1.0
  Positive (101) 93 (92.1%) 8 (7.9%)
Type III fimA
  Negative (98) 90 (91.8%) 8 (8.2%) 1.0
  Positive (5) 5 (100%) 0 (0.0%)
Type IV fimA
  Negative (90) 82 (91.1%) 8 (8.9%) 0.59
  Positive (13) 13 (100%) 0 (0.0%)
Type V fimA
  Negative (100) 92 (92.0%) 8 (8.0%) 1.0
  Positive (3) 3 (100%) 0 (0.0%)
P values less than 0.05 were considered statistically significant. 
Abbreviations: HCMV, human cytomegalovirus; P. gingivalis, 
Porphyromonas gingivalis; BOP, bleeding on probing.
Table 4- Associations of oral HCMV DNA with P. gingivalis and 
fimA genotypes
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periodontitis in middle-aged and older Japanese people 
(mean age in this study: 70.2 years). 
The association between PISA and oral HCMV 
has not been fully elucidated so far. In this study, no 
significant association was found between PISA and 
oral HCMV prevalence. Oral HCMV may be involved 
in local periodontal inflammation rather than total 
periodontal inflammation. Additionally, the low 
prevalence of HCMV may have caused false negative 
results in the statistical analysis of PISA. A further 
study will be required to clarify the association between 
oral CMV and PISA using a large number of HCMV-
positive cases. Furthermore, the presence of HCMV 
in inflamed periodontal pockets remains unclear. 
Additional investigation using resected inflamed 
periodontal tissue or crevicular fluid is necessary to 
identify the existence of HCMV in periodontal pockets.
Regarding oral herpes viruses other than HCMV, 
EBV is presumed to establish lifelong latent infections 
in the oral cavity.16 The specific histological structure 
of the tonsillar region may facilitate EBV infection, for 
lymphoid tissue is abundant in the tonsillar region. 
EBV can infect B lymphocytes through saliva. It can 
also infect epithelial cells.16 EBV amplification occurs 
Clinical factor (n) Patients without ≥4 mm periodontal 
pocket exhibiting BOP (n=62)
Patients with ≥4 mm periodontal pocket 
exhibiting BOP (n=62)
P-value
Age 68.4±10.5 69.7±11.3 0.34
Age in years
  30-39 (2) 1 (50.0%) 1 (50.0%) 0.95
  40-49 (5) 2 (40.0%) 3 (60.0%)
  50-59 (14) 8 (57.1%) 6 (42.9%)
  60-69 (37) 20 (54.1%) 17 (45.9%)
  70-79 (45) 22 (48.9%) 23 (51.1%)
  80-89 (21) 9 (42.9%) 12 (57.1%)
Sex
  Male (57) 29 (50.9%) 28 (49.1%) 1.0
  Female (67) 33 (49.3%) 34 (50.7%)
Heart disease 
  No (117) 58 (49.6%) 59 (50.4%) 1.0
  Yes (7) 4 (57.1%) 3 (42.9%)
Stroke
  No (120) 60 (50.0%) 60 (50.0%) 1.0
  Yes (4) 2 (50.0%) 2 (50.0%)
Hypertension
  No (90) 44 (48.9%) 46 (51.1%) 0.84
  Yes (34) 18 (52.9%) 16 (47.1%)
Diabetes
  No (108) 54 (50.0%) 54 (50.0%) 1.0
  Yes (16) 8 (50.0%) 8 (50.0%)
Hyperlipidemia
  No (99) 49 (49.5%) 50 (50.5%) 1.0
  Yes (25) 13 (52.0%) 12 (48.0%)
Smoking
  Non-smoker (99) 49 (49.5%) 50 (50.5%) 1.0
  Current/former smoker (25) 13 (52.0%) 12 (48.0%)
Remaining teeth 23.5±5.9 23.3±6.0 0.70
Denture user
  Non-user (93) 47 (50.5%) 46 (49.5%) 1.0
  User (31) 15 (48.4%) 16 (51.6%)
P values less than 0.05 were considered statistically significant. Abbreviation: BOP, bleeding on probing.
Table 5- Patients’ characteristics according to the presence of deep periodontal pockets with bleeding; comprising 124 propensity score-
matched patients.
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in epithelial cells, followed by shedding in saliva.17 
Thus, the oral cavity may play a major role in virus 
transmission to the nasopharynx and gastrointestinal 
tract. HCMV has been identified in oral epithelial cells 
by histochemical analysis.18 Thus, HCMV possibly infect 
epithelial cells through ulcerated gingival epithelium 
of the periodontal pocket. Considering the significant 
associations reported between EBV/HCMV prevalence 
and periodontitis,7,19,20 inflamed periodontal pockets 
may serve as a main reservoir of these herpes viruses 
in the oral cavity. 
Regarding the interaction between herpes viruses 
and bacteria related to periodontal disease, butyric 
acid produced by P. gingivalis has been shown to 
induce EBV reactivation via transcriptional activation 
of the BZLF1 gene.21 Butyric acid blocks the enzymatic 
activity of histone deacetylases by competing with 
histone deacetylase substrate binding at the catalytic 
site of the enzyme.22 Furthermore, P. gingivalis has 
been shown to induce human immunodeficiency 
virus-1 reactivation by chromatin modification, 
indicating that periodontal anaerobic bacteria may 
contribute to activation of latent viruses.23 These 
results highlight the significance of periodontopathic 
bacteria as activator of viral organisms. 
Proinflammatory cytokines and chemokines 
released by gingival fibroblasts infected with HCMV 
attract cytotoxic T cells and natural killer cells.7 In 
addition, pro-inflammatory cytokines may activate 
matrix metalloproteinases, resulting in periodontal 
ligament destruction and osteoclastic alveolar bone 
resorption.7 HCMV enhances immunosuppression 
by inhibiting cell surface expression of MHC class 
I molecules and activity of natural killer cells.24 
Therefore, HCMV considerably affects periodontal 
tissue destruction by inducing local proinflammatory 
cytokines and impairing the local host immune 
response. In this study, the presence of oral HCMV 
and P. gingivalis were significantly associated. 
Coinfection of herpes virus and bacteria related to 
periodontal disease increases the risk of chronic 
periodontitis.25,26 Moreover, HCMV induces the 
adherence of Actinobacillus actinomycetemcomitans to 
periodontal epithelial cells, suggesting that HCMV can 
enhance the virulence of bacteria related to periodontal 
disease.27 Therefore, HCMV causes severe periodontitis 
by enhancing the pathogenicity of periodontal bacteria. 
P. gingivalis produces several virulence factors (i.e., 
lipopolysaccharide, hemagglutinins, capsule, fimbriae, 
protease, gingipains, and others). Previous studies 
have demonstrated that lipopolysaccharide, fimbriae, 
and gingipains of P. gingivalis are significantly 
involved in periodontitis progression.28 P. gingivalis 
has the potential to destroy periodontal tissues with 
lipopolysaccharide-induced inflammatory cytokines, 
providing the HCMV with the chance to infect 
periodontal tissues. Therefore, HCMV is thought to 
depend on coinfection with P. gingivalis. Envelope 
glycoprotein B is a potential virulence factor of HCMV.29 
HCMV may also enhance the virulence of P. gingivalis 
by inhibiting the local host immune response.
This study had limitations. Clinical attachment loss 
can be used to evaluate the severity of periodontitis. 
However, the attachment level of the teeth was 
not measured in many participants. Therefore, the 
relationship between HCMV prevalence and the 
severity of periodontitis remains unclear. Furthermore, 
the small number of HCMV-positive cases may have 
affected the results of statistical analyses of plaque 
accumulation and the periodontal inflamed surface 
area.
In conclusion, oral HCMV was significantly 
associated with deep periodontal pockets with 
bleeding. We found that coinfection of oral HCMV 
and P. gingivalis is important for active periodontitis. 
Moreover, interactions between oral HCMV and P. 
gingivalis may be involved in the severity of periodontal 


















62 (52.5%) 56 (47.5%) 0.03
  Positive (6) 0 (0.0%) 6 (100%)
P. gingivalis
  Negative 
(55)
37 (67.3%) 18 (32.7%) <0.01
  Positive (69) 25 (36.2%) 44 (63.8%)
HCMV(+)/P. 
gingivalis(+)
  Yes (6) 0 (0.0%) 6 (100%) 0.03
  No (118) 62 (52.5%) 56 (47.5%)
P values less than 0.05 were considered statistically significant.
Abbreviations: HCMV; human cytomegalovirus; P. gingivalis, 
Porphyromonas gingivalis; BOP, bleeding on probing.
Table 6- Deep periodontal pockets with bleeding: associations 
with HCMV and P. gingivalis in 124 propensity score-matched 
patients
Oral human cytomegalovirus prevalence and its relationships with periodontitis and Porphyromonas gingivalis in Japanese adults: a cross-sectional study
J Appl Oral Sci. 2020;28:e202005019/10
between oral herpes viruses and bacteria related to 
periodontal disease in the pathology of periodontitis. 
Further prospective studies are necessary to confirm 
our findings and to clarify the association between 
persistent oral HCMV infection and periodontitis 
progression.
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